Medtronic plc, a global leader in healthcare technology, announced the United States Food and Drug Administration (FDA) has approval of the Affera Mapping and Ablation System with Sphere-9 catheter, ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system ...

An iconic annual gift catalog known for its extravagance has removed the word "Christmas" from its name after a nearly 100-year run. Neiman Marcus' "Christmas Book," in print since 1926 ...

(Update: Medtronic announced FDA approval for its Affera cardiac mapping and ablation system with the Sphere-9 catheter in October 2024.) Medtronic acquired the Sphere-9 catheter for pulsed field ...

For more information on Affera and the Sphere-9 catheter, visit Medtronic.com. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic ...

The Affera Mapping and Ablation System and Sphere-9 catheter also received CE Mark in March 2023 and was approved in Australia in September 2024. In October 2024, Medtronic announced the start of ...

GALWAY, Ireland - Medtronic plc (NYSE:MDT), a global healthcare technology leader, announced today that it has received FDA approval for its Affera Mapping and Ablation System with Sphere-9 Catheter.

Neiman Marcus has quietly removed the word “Christmas” from its iconic, 98-year-old annual gift catalog – and some company insiders gripe that the stealthy switch smacks of woke politics ...